|
|
|
|
LEADER |
02778nam a2200385 u 4500 |
001 |
EB001861000 |
003 |
EBX01000000000000001025096 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
190202 r ||| eng |
020 |
|
|
|a 9780309476959
|
020 |
|
|
|a 030947695X
|
100 |
1 |
|
|a English, Rebecca A.
|
245 |
0 |
0 |
|a Physician-assisted death
|h Elektronische Ressource
|b scanning the landscape : proceedings of a workshop
|c Rebecca A. English, Catharyn T. Liverman, Caroline M. Cilio, and Joe Alper, rapporteurs ; Board on Health Sciences Policy, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine
|
260 |
|
|
|a Washington, DC
|b The National Academies Press
|c 2018, [2018]
|
300 |
|
|
|a 1 PDF file (xiii, 164 pages)
|b illustrations
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Right to Die / legislation & jurisprudence
|
653 |
|
|
|a United States
|
653 |
|
|
|a Health Policy
|
653 |
|
|
|a Suicide, Assisted
|
653 |
|
|
|a Terminally Ill / psychology
|
653 |
|
|
|a Euthanasia, Active, Voluntary
|
700 |
1 |
|
|a Liverman, Catharyn T.
|e [rapporteur]
|
700 |
1 |
|
|a Cilio, Caroline M.
|e [rapporteur]
|
700 |
1 |
|
|a Alper, Joe
|e [rapporteur]
|
710 |
2 |
|
|a National Academies of Sciences, Engineering, and Medicine (U.S.)
|b Board on Health Sciences Policy
|
710 |
2 |
|
|a Physician-Assisted Death: Scanning the Landscape and Potential Approaches (Workshop) (2018, Washington, D.C.)
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK525934
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
082 |
0 |
|
|a 340
|
082 |
0 |
|
|a 100
|
520 |
|
|
|a The question of whether and under what circumstances terminally ill patients should be able to access life-ending medications with the aid of a physician is receiving increasing attention as a matter of public opinion and of public policy. Ethicists, clinicians, patients, and their families debate whether physician-assisted death ought to be a legal option for patients. While public opinion is divided and public policy debates include moral, ethical, and policy considerations, a demand for physician-assisted death persists among some patients, and the inconsistent legal terrain leaves a number of questions and challenges for health care providers to navigate when presented with patients considering or requesting physician-assisted death. To discuss what is known and not known empirically about the practice of physician-assisted death, the National Academies of Sciences, Engineering, and Medicine convened a 2-day workshop in Washington, DC, on February 12-13, 2018. This publication summarizes the presentations and discussions from the workshop
|